Apyx Medical Statistics
Total Valuation
Apyx Medical has a market cap or net worth of $46.77 million. The enterprise value is $48.11 million.
Market Cap | 46.77M |
Enterprise Value | 48.11M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, after market close.
Earnings Date | Aug 8, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Apyx Medical has 34.64 million shares outstanding. The number of shares has increased by 0.13% in one year.
Shares Outstanding | 34.64M |
Shares Change (YoY) | +0.13% |
Shares Change (QoQ) | +0.06% |
Owned by Insiders (%) | 17.97% |
Owned by Institutions (%) | 38.58% |
Float | 25.59M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.93 |
Forward PS | 0.91 |
PB Ratio | 2.31 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.95 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.87, with a Debt / Equity ratio of 1.91.
Current Ratio | 5.87 |
Quick Ratio | 4.71 |
Debt / Equity | 1.91 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -5.30 |
Financial Efficiency
Return on equity (ROE) is -78.00% and return on invested capital (ROIC) is -35.59%.
Return on Equity (ROE) | -78.00% |
Return on Assets (ROA) | -33.60% |
Return on Capital (ROIC) | -35.59% |
Revenue Per Employee | $200,202 |
Profits Per Employee | -$90,500 |
Employee Count | 252 |
Asset Turnover | 0.74 |
Inventory Turnover | 1.77 |
Taxes
Income Tax | -112,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.00% in the last 52 weeks. The beta is 1.21, so Apyx Medical's price volatility has been higher than the market average.
Beta (5Y) | 1.21 |
52-Week Price Change | -77.00% |
50-Day Moving Average | 1.47 |
200-Day Moving Average | 1.96 |
Relative Strength Index (RSI) | 44.10 |
Average Volume (20 Days) | 24,055 |
Short Selling Information
The latest short interest is 291,494, so 0.84% of the outstanding shares have been sold short.
Short Interest | 291,494 |
Short Previous Month | 298,924 |
Short % of Shares Out | 0.84% |
Short % of Float | 1.14% |
Short Ratio (days to cover) | 6.90 |
Income Statement
In the last 12 months, Apyx Medical had revenue of $50.45 million and -$22.81 million in losses. Loss per share was -$0.66.
Revenue | 50.45M |
Gross Profit | 32.14M |
Operating Income | -20.96M |
Pretax Income | -22.92M |
Net Income | -22.81M |
EBITDA | -18.51M |
EBIT | -19.28M |
Loss Per Share | -$0.66 |
Balance Sheet
The company has $37.28 million in cash and $38.63 million in debt, giving a net cash position of -$1.34 million or -$0.04 per share.
Cash & Cash Equivalents | 37.28M |
Total Debt | 38.63M |
Net Cash | -1.34M |
Net Cash Per Share | -$0.04 |
Equity (Book Value) | 20.25M |
Book Value Per Share | 0.58 |
Working Capital | 51.37M |
Cash Flow
In the last 12 months, operating cash flow was -$9.71 million and capital expenditures $6.81 million, giving a free cash flow of -$2.90 million.
Operating Cash Flow | -9.71M |
Capital Expenditures | 6.81M |
Free Cash Flow | -2.90M |
FCF Per Share | -$0.08 |
Margins
Gross margin is 63.70%, with operating and profit margins of -41.54% and -45.20%.
Gross Margin | 63.70% |
Operating Margin | -41.54% |
Pretax Margin | -45.43% |
Profit Margin | -45.20% |
EBITDA Margin | -36.70% |
EBIT Margin | -38.21% |
FCF Margin | -5.75% |
Dividends & Yields
Apyx Medical does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.13% |
Shareholder Yield | -0.13% |
Earnings Yield | -48.76% |
FCF Yield | -6.20% |
Analyst Forecast
The average price target for Apyx Medical is $4.75, which is 251.85% higher than the current price. The consensus rating is "Buy".
Price Target | $4.75 |
Price Target Difference | 251.85% |
Analyst Consensus | Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | 12.28% |
EPS Growth Forecast (5Y) | -43.68% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Apyx Medical has an Altman Z-Score of 0.02 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.02 |
Piotroski F-Score | 2 |